V
Edit properties
Sector
Biotech
Status
active
Stage
Series B
HQ City
—
Subsector
rare vascular disease
Founded
—
AKA
—
Website
—
Notes
—
+ Add financial data — ARR, revenue, headcount, EBITDA
Latest news
From Google NewsNo news yet. Click Refresh to pull from Google News.
Funding Rounds
| Round | Amount | Post-Money Val. | Date | Lead | All Investors | |
|---|---|---|---|---|---|---|
| Series B | $152M | — | 2026-08-11 | Goldman Sachs Alternatives, TCGX, Omega and EQT | Goldman Sachs Alternatives, TCGX, Omega, EQT | ↗ comps |